Arthur M. Cohen & Associates’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$351K Sell
4,930
-59
-1% -$4.42K 0.06% 99
2025
Q4
$394K Buy
4,989
+300
+6% +$23.7K 0.06% 92
2025
Q3
$386K Hold
4,689
0.06% 96
2025
Q2
$377K Buy
4,689
+1,930
+70% +$149K 0.07% 98
2025
Q1
$222K Sell
2,759
-370
-12% -$30.8K 0.04% 121
2024
Q4
$256K Buy
3,129
+470
+18% +$39.1K 0.05% 121
2024
Q3
$217K Buy
+2,659
New +$199K 0.04% 132

Other funds holding MET

Arthur M. Cohen & Associates's MET Position: Q1 2026 in Review

Arthur M. Cohen & Associates reduced its MetLife (MET) stake by 1.2% in Q1 2026, selling an estimated $4.42K and leaving 4,930 shares worth $351K. The position accounts for 0.06% of the portfolio, ranked #99.

Arthur M. Cohen & Associates first reported a position in MET in Q3 2024 and has held it in 7 quarters since. The position peaked at $394K in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Arthur M. Cohen & Associates held 4,930 shares of MetLife worth $351K as of Q1 2026.
  • Arthur M. Cohen & Associates sold 59 MetLife shares in Q1 2026, an estimated $4.42K.
  • MetLife made up 0.06% of Arthur M. Cohen & Associates's portfolio in Q1 2026, its #99 holding.
  • Arthur M. Cohen & Associates first reported a position in MetLife in Q3 2024 and has held it in 7 quarters since.
  • Arthur M. Cohen & Associates's MetLife position peaked at $394K in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2026, filed 8 May 2026.